Posters
Long-term outcome of cataract surgery for high myopic patients with myopia traction maculopathy
Poster Details
First Author: J. Yang CHINA
Co Author(s): L. Cai Y. Lu
Abstract Details
Purpose:
To investigate the long-term result of cataract surgery for high myopic patients with myopic traction maculopathy (MTM) and to identify the factors associated with its progression or resolution.
Setting:
Department of Ophthalmology, Eye & ENT Hospital of Fudan University,Shanghai,China
Myopia Key Laboratory of Health P R China, Shanghai, China
Methods:
Highly myopic eyes with MTM, who underwent phacoemulsification surgery, were included. Patients were followed preoperatively and at postoperative month 1, and at year 1, 2 and 3, when the examination of OCT and MP-1 were performed. The eyes were classified into 3 groups based on the size of the macular retinoschisis. The MS, best corrected visual acuity (BCVA) in Log MAR, and status of the myopic traction maculopathy was recorded at every visit
Results:
112 eyes with MTM were included. Both the BCVA and MS were improved significantly at 1 month after surgery (t=17.871, p<0.05; t=-9.779, p<0.05). The OCT examination showed no improvement or progression at 1-month visit. At the final examination, of the 112 eyes, 8 (7.1%) experienced progression of the myopic traction maculopathy, and 3 eyes (2.7%) showed a decrease of the macular retinoschisis. At the final examination, the BCVA was significantly worse than that at 1-month examination only in the patients whose MTM had progressed (p<0.05). However, the MS decreased significantly at final examinations when comparing to that at 1-month visit in both the group with stable MTM (p<0.05) and the group in whom the MTM had progressed (p<0.05)
Conclusions:
Both the BCVA and MS were improved after the cataract surgery. The course of myopic traction maculopathy after cataract surgery varies, and eyes with more extensive macular retinoschisis tend to progress more commonly. These findings can be used to determine whether surgery should be performed
Financial Disclosure:
NONE